Synonyms: 17-hydro-9-dehydro-andrographolide; andrographolide; Andropanolide; 3-(2-(Decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenenaphthyl)ethylidene)dihydro-4-hydroxyfuran-2(3H)-one; EINECS 226-852-5; NSC 383468; 3alpha,14,15,18-tetrahydroxy-5b,9bH,10a-labda-8(20),12-dien-16-oic acid gamma-Lactone; (1R-(1-alpha(E(S)),4abeta,5alpha,6alpha,8aalpha))-3-(2-(decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl)ethylidene)dihydro-4-hydroxy-2(3H)-furanone; (3E,4S)-3-[2-[(1R,4aS,5R,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]ethylidene]-4-hydroxyoxolan-2-one; (3E,4S)-4-hydroxy-3-{2-[(1R,4aS,5R,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidenedecahydronaphthalen-1-yl]ethylidene}dihydrofuran-2(3H)-one; NSC383468; NCGC00095597-01; isoandrographolide; AK-47364; Andrographolide, 98%; AC1NSWY5; DSSTox_CID_25980; DSSTox_RID_81270; DSSTox_GSID_45980; BIDD:ER0530; CHEMBL186141; GTPL9675; MEGxp0_000978; Andrographolide; DTXSID3045980; SCHEMBL12056309; ACon1_002113; BOJKULTULYSRAS-OTESTREVSA-N; 2(3H)-Furanone, 3-(2-(decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl)ethylidene)dihydro-4-hydroxy-, (1R-(1-alpha(E(S*)),4a-beta,5-alpha,6-alpha,8a-alpha))-; 869807-57-8; ACT03252; Andrographolide, analytical standard; HY-N0191; ZINC3881797; 5508-58-7; Tox21_111508; BDBM50084419; CA0137; MFCD07778082; AKOS015920075; CCG-208428; CS-3334; DB05767; MCULE-5521128905; NCGC00179817-01; Andrographis; 2(3H)-Furanone, 3-[2-[(1R,4aS,5R,6R,8aS)-decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl]ethylidene]dihydro-4-hydroxy-, (3E,4S)-; AJ-46652; AS-13637; BR-47364; SC-46922; CAS-5508-58-7; AX8009106; ST2414690; C20214; J10022; UNII-410105JHGR; S-1899; 508A587; Q-100624; BRD-K89282837-001-01-0; Andrographolide, United States Pharmacopeia (USP) Reference Standard; (3E,4S)-3-[2-[(1R,4aS,5R,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-decalin-1-yl]ethylidene]-4-hydroxy-tetrahydrofuran-2-one; (3E,4S)-3-{2-[(1R,4aS,5R,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1H-naphthalen-1-yl]ethylidene}-4-hydroxyoxolan-2-one; (5beta,9R,10alpha,14S)-3alpha,14,15,18-Tetrahydroxylabdane-8(20),12-diene-16-oic acid gamma-lactone; (S,E)-4-Hydroxy-3-(2-((1R,4aS,5R,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenedecahydronaphthalen-1-yl)ethylidene)dihydrofuran-2; 2(3H)-Furanone,3-[2-[(1R,4aS,5R,6R,8aS)-decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl]ethylidene]dihydro-4-hydroxy-,(3E,4S)-; CHEBI:65408; Andro; isoandrographolide; D04VIS; C20H30O5; 17-hydro-9-dehydro-andrographolide; ACN-035327; C20-H30-O5; CID5318517; A2459; C030419; 410105JHGR; Andrographolide, 98%, from Andrographis paniculata (Burm. f.) Nees - 1G 1g; 2(3H)-Furanone, 3-[2-[decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl]ethylidene]dihydro-4-hydroxy-; 3-[2-[decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenenaphthyl]ethylidene]dihydro-4-hydroxyfuran-2(3H)-one; 3-alpha,14,15,18-tetrahydroxy-5beta,9beta H,10-alpha-labda-8(20),12-dien-16-oic acid gamma-lactone; 5.beta.,9.beta.H,10.alpha.-Labda-8(20),12-dien-16-oic acid, 3.alpha.,14,15,18-tetrahydroxy-, .gamma.-lactone; (S,E)-4-Hydroxy-3-(2-((1R,4aS,5R,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenedecahydronaphthalen-1-yl)ethylidene)dihydrofuran-2(3H)-one;